Pilot study of radiation oncology peer review in low middle income country (LMIC) through cloud-based platform.

Manjinder S Sidhu, Garima Gokhroo, Suneetha Mulinti, Mangesh B Pati, Midhun Murali, Vibhor Gupta, Suresh Chaudhari, Kareem Rayn, Sushil Beriwal
{"title":"Pilot study of radiation oncology peer review in low middle income country (LMIC) through cloud-based platform.","authors":"Manjinder S Sidhu, Garima Gokhroo, Suneetha Mulinti, Mangesh B Pati, Midhun Murali, Vibhor Gupta, Suresh Chaudhari, Kareem Rayn, Sushil Beriwal","doi":"10.4103/jcrt.jcrt_1697_23","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Peer review is an essential step in clinical quality assurance for radiation therapy. There are very little data on peer reviews from low-middle-income countries (LMIC). With increasing access to advanced technologies in LMIC also, peer review is becoming more important to ensure quality and standard of care. We evaluated cloud-based e-Peer review in our network of cancer centers in India with an aim to study its feasibility and impact on care.</p><p><strong>Materials and methods: </strong>Four out of 13 cancer centers across India were selected for this pilot study. All team members were trained on the e-Peer review platform before the initiation of the study. A lead dosimetrist from a centralized planning site was selected to share new cases every week. Cases treated with only definitive intent were selected. The link to the cases was sent through an email to reviewing physicians. The following aspects were reviewed for each case. 1) Work up and staging. 2) Treatment intent and prescription. 3) Target contours. 4) Normal organ at risk contours. 5) Dose-volume-histogram (DVH) with clinical goals attached. Cases were marked as \"Not Appropriate,\" \"Appropriate,\" \"Appropriate with minor finding,\" and \"Represent with major revisions\" as per volume and plan review.</p><p><strong>Results: </strong>Over a period of 3 months, 100 cases underwent peer review before the start of treatment. Median turnover time was 48 (interquartile range: 24-96) hours. The median time for review was 8 min with time to review cases requiring major and minor changes being 12 and 6 min, respectively (P < 0.001). Of all the cases reviewed, no changes, minor changes, and major changes were suggested for 36%, 48%, and 16% of cases, respectively. The most frequent reason for major changes was contouring corrections (15%). Also, 31.3% of major changes underwent recontouring and replanning before initiation of treatment.</p><p><strong>Conclusion: </strong>Peer review was feasible in our setting through this cloud-based peer review system, with median turnover time and time taken for review being 48 h and 8 min, respectively. Like published data from the Western world, peer review led to changes that could impact patient care delivery and outcome. We plan to implement this across the remaining centers in our network.</p>","PeriodicalId":94070,"journal":{"name":"Journal of cancer research and therapeutics","volume":"20 5","pages":"1591-1594"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cancer research and therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jcrt.jcrt_1697_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Peer review is an essential step in clinical quality assurance for radiation therapy. There are very little data on peer reviews from low-middle-income countries (LMIC). With increasing access to advanced technologies in LMIC also, peer review is becoming more important to ensure quality and standard of care. We evaluated cloud-based e-Peer review in our network of cancer centers in India with an aim to study its feasibility and impact on care.

Materials and methods: Four out of 13 cancer centers across India were selected for this pilot study. All team members were trained on the e-Peer review platform before the initiation of the study. A lead dosimetrist from a centralized planning site was selected to share new cases every week. Cases treated with only definitive intent were selected. The link to the cases was sent through an email to reviewing physicians. The following aspects were reviewed for each case. 1) Work up and staging. 2) Treatment intent and prescription. 3) Target contours. 4) Normal organ at risk contours. 5) Dose-volume-histogram (DVH) with clinical goals attached. Cases were marked as "Not Appropriate," "Appropriate," "Appropriate with minor finding," and "Represent with major revisions" as per volume and plan review.

Results: Over a period of 3 months, 100 cases underwent peer review before the start of treatment. Median turnover time was 48 (interquartile range: 24-96) hours. The median time for review was 8 min with time to review cases requiring major and minor changes being 12 and 6 min, respectively (P < 0.001). Of all the cases reviewed, no changes, minor changes, and major changes were suggested for 36%, 48%, and 16% of cases, respectively. The most frequent reason for major changes was contouring corrections (15%). Also, 31.3% of major changes underwent recontouring and replanning before initiation of treatment.

Conclusion: Peer review was feasible in our setting through this cloud-based peer review system, with median turnover time and time taken for review being 48 h and 8 min, respectively. Like published data from the Western world, peer review led to changes that could impact patient care delivery and outcome. We plan to implement this across the remaining centers in our network.

通过云平台在中低收入国家(LMIC)开展放射肿瘤同行评审试点研究。
目的:同行评审是放射治疗临床质量保证的重要步骤。中低收入国家(LMIC)的同行评审数据非常少。随着中低收入国家越来越多地使用先进技术,同行评审对于确保医疗质量和标准也变得越来越重要。我们在印度的癌症中心网络中对基于云的电子同行评审进行了评估,旨在研究其可行性和对护理的影响:在印度的 13 家癌症中心中选择了四家进行试点研究。研究开始前,所有团队成员都接受了电子同行评审平台的培训。从一个集中规划点选出一名主要剂量测定师,每周分享新病例。所选病例仅为确诊治疗病例。病例链接通过电子邮件发送给审查医生。对每个病例进行以下方面的审查。1) 检查和分期。2) 治疗意图和处方。3) 目标轮廓。4) 有风险的正常器官轮廓。5) 附有临床目标的剂量-容量-组图(DVH)。根据数量和计划审查结果,病例被标记为 "不合适"、"合适"、"合适但有小的发现 "和 "有重大修改的代表":在 3 个月的时间里,有 100 个病例在治疗开始前接受了同行评审。周转时间中位数为 48 小时(四分位间范围:24-96 小时)。审查时间的中位数为 8 分钟,需要进行重大和轻微修改的病例审查时间分别为 12 分钟和 6 分钟(P < 0.001)。在所有复查病例中,建议不作修改、作小修改和作大修改的病例分别占 36%、48% 和 16%。主要修改的最常见原因是轮廓修正(15%)。此外,31.3%的重大改动在开始治疗前进行了重新塑形和重新规划:结论:通过基于云的同行评审系统进行同行评审在我们这里是可行的,中位周转时间和评审时间分别为 48 小时和 8 分钟。与西方国家已公布的数据一样,同行评审带来的改变可能会影响患者的治疗效果。我们计划在我们网络中的其余中心实施这一系统。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信